GB0108817A
GB0108817D0
(en)
|
2001-04-06 |
2001-04-06 |
Therapy
|
EP08016235A
EP2058332A1
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 binding molecules in steroid-resistant patients
|
NZ528411A
NZ528411A
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 binding molecules in steroid-resistant patients and improving the response to steroid therapy in steroid-sensitive patients
|
EP02740446A
EP1379557B1
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
BR0208656-5A
BR0208656A
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 ligand molecules in steroid resistant patients
|
JP2002579494A
JP2005502593A
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 binding molecules in steroid resistant patients
|
CZ20032672A
CZ20032672A3
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 binding molecules in the prevention or treatment of some diseases in a steroid-resistant patient
|
US10/474,071
US20040146508A1
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
PCT/EP2002/003808
WO2002081508A2
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
RU2003130636/15A
RU2318537C2
(en)
|
2001-04-06 |
2002-04-05 |
Application of cd25-binding molecules for treatment of steroid-resistant patients
|
ES02740446T
ES2314067T3
(en)
|
2001-04-06 |
2002-04-05 |
USE OF CD 25 LINK MOLECULES IN STEROID RESISTANT PATIENTS.
|
DE60228945T
DE60228945D1
(en)
|
2001-04-06 |
2002-04-05 |
USE OF CD25-BINDING MOLECULES FOR PATIENTS WITH STEROID RESISTANCE
|
CA002443405A
CA2443405A1
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
AU2002315271A
AU2002315271B2
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 binding molecules in steroid-resistant patients
|
PT02740446T
PT1379557E
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
HU0400986A
HUP0400986A3
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
SK1221-2003A
SK12212003A3
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 binding molecules in steroid-resistant patients
|
IL15806002A
IL158060A0
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
PL02363029A
PL363029A1
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
AT02740446T
ATE408629T1
(en)
|
2001-04-06 |
2002-04-05 |
USE OF CD25-BINDING MOLECULES FOR PATIENTS WITH STEROID RESISTANCE
|
KR1020037012923A
KR100975042B1
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD25 Binding Molecules in Steroid-Resistant Patients
|
MXPA03009115A
MXPA03009115A
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients.
|
CNB028074807A
CN1296386C
(en)
|
2001-04-06 |
2002-04-05 |
Use of CD 25 binding molecules in steroid-resistant patients
|
KR1020087028908A
KR20080110687A
(en)
|
2001-04-06 |
2002-04-05 |
Use of cd25 binding molecules in steroid-resistant patients
|
IL158060A
IL158060A
(en)
|
2001-04-06 |
2003-09-22 |
Cd25 binding molecules for use in the prevention or treatment of diseases in steroid-resistant patients
|
NO20034453A
NO20034453L
(en)
|
2001-04-06 |
2003-10-03 |
Use of CD25-binding molecules in steroid-resistant patients
|
JP2008328042A
JP2009102367A
(en)
|
2001-04-06 |
2008-12-24 |
Use of cd25 binding molecule in steroid-resistant patient
|
US12/378,454
US20090274691A1
(en)
|
2001-04-06 |
2009-02-13 |
Use of CD25 binding molecules in steroid-resistant patients
|